Showing posts with label embryo transfer. Show all posts
Showing posts with label embryo transfer. Show all posts

Monday, April 16, 2018

Fresh or frozen-embryo transfer results in similar pregnancy rates in women without PCOS

Episona.com

Healthy infertile women with no polycystic ovarian syndrome have the same ongoing pregnancy and live birth rates from IVF irrespective of whether the embryo was fresh or frozen reports the results of two recent clinical trials published in JAMA. 

Recent clinical trials have documented higher pregnancy and live birth rates with the transfer of frozen embryos as compared to fresh ones. A clinical review published in the Journal of Human Reproduction Update also favored “elective frozen embryo transfer (eFET) not only in terms of achieving higher pregnancy rates but, more importantly, also in terms of lower maternal and infant morbidity and mortality.”

The two current studies were conducted to see whether fresh frozen embryo transfer resulted in higher birthrates in women who do not have PCOS.

The first multicenter, randomized trial recruited 2157 women who were scheduled to undergo their first IVF cycles. They were randomly assigned to undergo either fresh-embryo transfer or embryo cryopreservation followed by frozen-embryo transfer. The maximum embryo transferred in each participant was two with the live birth rate as the primary outcome after the first embryo transfer.

There was no significant difference in terms of live birth rates in the frozen-embryo group and the fresh-embryo group (48.7% and 50.2%; P=0.50) respectively. Both the groups were also similar in terms of risks of obstetrical and neonatal complications, rates of implantation, clinical pregnancy, overall pregnancy loss, and ongoing pregnancy.

But, frozen embryo transfer did result in a significantly lower risk of the ovarian hyperstimulation syndrome than fresh-embryo transfer (0.6% vs. 2.0%; P=0.005).

The second study randomly assigned 782 healthy infertile women with no PCOS to receive either a frozen embryo or a fresh embryo on day 3 during their first or second IVF. In this study also, the pregnancy rates were comparable in both the groups, 36.3% in the frozen-embryo group 34.5% in the fresh-embryo group (P = .65).

The authors concluded that in women who do not have PCOS, the pregnancy rates are similar with fresh or frozen embryos. In healthy infertile women, probably the uterine environment was favorable for fresh embryos transfer. 

Saturday, March 18, 2017

ASRM's guidelines for the limits on the number of embryos transferred in In Vitro Fertilization (IVF) cycles.

courtesy: https://sickbayby.wordpress.com/tag/multiple-gestation/


In order to promote singleton pregnancies and bring down the number of multiple pregnancies in patients undergoing IVF, American Society for Reproductive Medicine (ASRM) and Society for Assisted Reproductive Technology (SART) updated the guidelines regarding the upper limit number of embryos transferred in IVF cycle. These guidelines replace the previous guidance issued in 2013.

The guidelines were  published online in the forthcoming issue of Journal of Fertility and Sterility.

The incidence of triplets and higher order multiple births have essentially declined in US for the last 15 years after steadily rising fourfold during the 1980s and 1990s. But, still multiple births are not desirable outcome of ART therapy.

The rise was due to older maternal age and increased use of ARTs, with no guidelines on the number of embryos transferred.
                                                     
Triplets
Triplets and Higher order births continue to have poor prognosis with 7% succumbing in first year of life as compared to .5% of singleton pregnancies. The ideal outcome after an ART procedure is to have a singleton pregnancy.

National data from CDC in 2013 demonstrate that clinics that perform higher rates of elective single-embryo transfer (eSET) in women aged <38 years have decreased rates of multiple gestation, with no significant impact on cumulative live-birth rates.

In women who are 42 years or younger transferring a single euploid blastocyst resulted in pregnancy rates similar to transferring two untested blastocysts while dramatically reducing the risk of twins.

Patient has the choice to choose the number of embryos transferred but it should be a fully informed decision taking into consideration medical, ethical and financial aspects of the procedure.

For drafting the recommendations, the patients have been categorized into favorable prognosis group and all others.

Conditions associated with favorable outcome are young age: euploid embryos, one or more good quality embryo available for cryopreservation and previous history of livebirth after an ART cycle.
For frozen embryo transfer the favorable conditions are when high quality, vitrified, day 5 or 6 blastocysts available.

The number of embryo transferred should be agreed upon by the treating physician and patients, depending upon the patient characteristics, data for the individual procedure and data from the ART services provided by the clinic. The following guidelines recommend the upper limits of the number of embryo transferred.

Patient with favorable prognosis:

A single euploid embryo transferred in patient of any age has the most favorable prognosis.

Patients under the age of 35 are always encouraged to receive one single embryo, irrespective of the embryo stage.  

Similarly, for patients between 35-37 years of age, a single embryo transfer is encouraged.

Patient between 38-40years of age, a single euploid embryo should be transferred, if availability is restricted than three cleavage-stage embryos or two blastocysts should be transferred.

Similarly, for patients between 41-42 years of age, the choice is to transfer single euploid embryo, if not than four cleavage-stage embryos or three blastocysts is the second choice.

Other scenarios:

In each of the above age group, if the patients do not belong to favorable prognosis category they can receive an additional embryo based on individual circumstances.

If patients who are in favorable prognosis category but fail to conceive after repeated cycles than an additional embryo may be transferred. If these patients have some coexisting medical condition that put them at high risk because of multiple gestation, a single embryo transfer is recommended.

In cases where the number of blastocysts transfer exceed the recommended limit, patient should receive counselling and everything should be well documented on the medical record.

Patients who are more than 43 years of age, insufficient data exist for number of embryos to be transferred using her own oocytes. The risk of multiple pregnancy increases dramatically as age increases, so caution must be exercised.

In donor-oocyte cycles decision should be made according to donor's age.

In frozen embryo transfer cycles, the patient should be categorized into favorable/other scenarios  group according to age of women when the embryo was frozen. And the number of frozen embryo transferred should not exceed the number of fresh embryo transfer recommended for each age group.

The full article in the Journal of Fertility and Sterility can be accessed here.


Friday, July 1, 2016

Does intentional endometrial curettage before embryo transfer increases the chances of successful outcome?

Clinical pearls:


  • Current research points in favor of performing endometrial scratching between day 7 of previous cycle to day 7 of the embryo transfer cycle resulting in improvement in clinical pregnancy rate and live birth rates in women with more than two previous embryo transfers. 

It is proposed that endometrial scratching or biopsy increases the chances of implantation in women attempting ARTs. With an intention to determine the current practice clinicians across Australia, New Zealand and the UK were given an on-line survey between August to October 2015.  The results of this study was published in the recent issue of Human Reproduction.[1]

In this cross- sectional study spanning 143 private and public fertility centers, 89% of physicians, embryologists and nurses perform the endometrial biopsy or scratching as a part of treatment protocols for couples undergoing IVF.[2]

The most common indication (92%) for the procedure was Recurrent Implantation failure (RIF) while only 3.6% clinicians offered it to patients trying to conceive by natural intercourse or IUI. Although many trials exist documenting the benefit of this procedure in couple trying to conceive naturally. [3]  
It was interesting to see that they all followed different time frame for doing the procedure.
89% of the centers offered the procedure in the luteal phase of the cycle prior to the embryo transfer cycle and none performed it on the day of egg retrieval or embryo-transfer.  
Two- thirds of the responders agreed that it is very useful in RIF undergoing IVF and more than 50% did not think it to be useful before the first IVF cycle.

Currently the most accepted explanation for the success is favorable immune modulation of the endometrium increasing the implantation rate. Other theories are it modulates the gene expression and increases the receptivity. [4]

A review of literature finds many RCTs conducted in the past to gauge the benefit of the procedure.
Results of Cochrane systemic review of 14 Randomized control trial(RCTs) shows that endometrial injury before starting the ovarian stimulation improves the chances of conception and ongoing pregnancy.[5] The evidence is moderate grade and suggests that “Endometrial injury performed between day 7 of the previous cycle and day 7 of the embryo transfer (ET) cycle is associated with an improvement in live birth and clinical pregnancy rates in women with more than two previous embryo transfers.”

With all these evidence pointing in favor of the procedure, a very large and robust study with sufficient power by Yeung et al[6] published in Human Reproduction showed that the procedure does not offer any benefits contrary to the previous beliefs. But, in this study about 70% of the patients received the procedure in their first IVF cycle so the results may not be generalized to patients with RIF.

To conclude, although current evidence is in favor of endometrial scratching, more evidence is needed in the form of large, randomized clinical trials regarding its timing in relation to menstrual cycle, use in women with or without RIF and its use in natural cycles, before this inexpensive and simple procedure can be widely applied in fertility clinics.





[1] http://humrep.oxfordjournals.org/content/31/6/1241.abstract
[2] http://humrep.oxfordjournals.org/content/31/6/1241.full.pdf+html
[3] Gibreel A, Badawy A, El-Refai W, El-Adawi N. Endometrial scratching to improve pregnancy rate in couples with unexplained subfertility: a randomized controlled trial. J Obstet Gynaecol Res 2013;39:680 – 684.
[4] Zhou L,Li RWang RHuang H-xZhong KLocal injury to the endometrium in controlled ovarian hyperstimulation cycles improves implantation rates. Fertil Steril2008;89:1166-1176.
[5] http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009517.pub3/pdf